Labiotech.eu is an online publication covering the global biotech industry, with a mix of news and in-depth analysis. Updated daily, the site also includes a weekly podcast.

Biotech royalty deals on the rise and here to stay
51:19
Biotech royalty deals on the rise and here to stay
Contraline's ADAM in the clinic: towards a new era of male contraception?
40:34
Contraline's ADAM in the clinic: towards a new era of male contraception?
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
44:50
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
What’s next in immunology & inflammation R&D: The trends to watch
51:26
What’s next in immunology & inflammation R&D: The trends to watch
BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year
44:55
BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year
AION Labs is building innovative biotechs with top pharma partners in Israel
42:10
AION Labs is building innovative biotechs with top pharma partners in Israel
Navigating the biotech development journey from first steps to global scale with Lonza
50:42
Navigating the biotech development journey from first steps to global scale with Lonza
A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox ...
38:03
A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox ...
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions
48:02
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions
Are next-generation psychedelics the way forward for addressing treatment resistant depression?
49:08
Are next-generation psychedelics the way forward for addressing treatment resistant depression?
Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn
49:58
Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn
Meatly's innovative cultivated meat is already delighting pets, are humans next?
38:46
Meatly's innovative cultivated meat is already delighting pets, are humans next?
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience
48:31
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience
InflaRx takes on inflammation with first-in-class C5a/C5aR signaling pathway strategy
39:25
InflaRx takes on inflammation with first-in-class C5a/C5aR signaling pathway strategy
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
34:28
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms
38:30
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
36:28
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Special Episode: The 2025 BIO International Convention
38:21
Special Episode: The 2025 BIO International Convention
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
46:27
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
42:13
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie
39:28
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie
How generative AI and 'Photoshop for proteins' are transforming biopharma R&D
35:01
How generative AI and 'Photoshop for proteins' are transforming biopharma R&D
Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells
33:53
Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells
Inside Flagship Pioneering's strategy: How this VC turns ideas into biotech giants
44:26
Inside Flagship Pioneering's strategy: How this VC turns ideas into biotech giants
TCR-NK: A novel cell therapy transforming cancer treatment
34:01
TCR-NK: A novel cell therapy transforming cancer treatment
AI in biotech today, and how it will impact the industry tomorrow
39:41
AI in biotech today, and how it will impact the industry tomorrow
MoonLake Immunotherapeutics’ Kristian Reich on how nanobodies will revolutionize immunotherapy
41:14
MoonLake Immunotherapeutics’ Kristian Reich on how nanobodies will revolutionize immunotherapy
Meeting the global demand for cell therapies: scaling with smart manufacturing
39:39
Meeting the global demand for cell therapies: scaling with smart manufacturing
Can stem cells transform spinal cord injury treatment? Lineage Cell Therapeutics thinks so.
33:49
Can stem cells transform spinal cord injury treatment? Lineage Cell Therapeutics thinks so.
Mitochondrial therapeutics: The future of aging and neurodegenerative disease?
37:48
Mitochondrial therapeutics: The future of aging and neurodegenerative disease?